Benign neoplasm: Small intestine

CD2_BENIGN_SMALL_INTESTINE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints CD2_BENIGN_DUODENUM CD2_BENIGN_SMALL_INTESTINE_OTH CD2_BENIGN_LIVER_BILE_9	1382
6. Filter based on genotype QC (FinnGen only)	1382

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_SMALL_INTESTINE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_DUODENUM\|CD2_BENIGN_SMALL_INTESTINE_OTH\|CD2_BENIGN_LIVER_BILE_9
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Small intestine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7837	4216	3574
Only index persons	6967	3829	3138
Unadjusted period prevalence (%)
Whole population	0.11	0.12	0.10
Only index persons	0.13	0.14	0.12
Median age at first event (years)
Whole population	64.82	64.43	65.25
Only index persons	64.27	63.88	64.75

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1382	778	604
Unadjusted period prevalence (%)	0.27	0.27	0.27
Median age at first event (years)	63.28	61.65	65.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1258: Matched controls
12580

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

+∞

323.0

765

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

+∞

323.0

480

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

16.0

323.0

1021

2663

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

17.2

112.2

183

123

UJF32

NOMESCO Finland

Coloscopy

3.9

103.9

608

2442

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

21.1

94.9

143

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

69.1

78.6

JDH05

NOMESCO Finland

Endoscopic polypectomy in duodenum

+∞

60.9

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.7

57.8

219

545

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

56.3

570

2973

UJF92

NOMESCO Finland

Capsular endoscopy

12.6

56.3

103

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

34.1

54.5

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

5.3

50.6

165

347

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.4

47.5

189

489

A02BC02

ATC

pantoprazole; systemic

2.5

45.4

939

6818

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.4

44.1

245

839

SPAT1236

SPAT

Informing family of child’s disability

9.0

42.6

111

UJF30

NOMESCO Finland

Ileoscopy through colon

3.6

42.3

216

692

Z71.9

ICD-10 Finland

Counselling, unspecified

4.8

40.5

144

330

A02BC05

ATC

esomeprazole; systemic

2.2

40.3

628

3870

D64.9

ICD-10 Finland

Anaemia, unspecified

3.2

38.9

230

820

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.2

37.4

221

783

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.1

37.1

233

863

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.5

36.9

348

1651

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.6

36.7

159

UJF02

NOMESCO Finland

Peroral enteroscopy

21.6

35.5

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

35.2

361

1785

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.3

34.4

137

351

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

11.4

34.2

Z51.88

ICD-10 Finland

Other specified medical care

8.0

33.9

105

A02BC01

ATC

omeprazole; systemic

2.2

33.8

452

2536

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

9.5

32.1

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

16.2

30.9

JFB00

NOMESCO Finland

Partial resection of small intestine

9.2

30.7

Z2221

NOMESCO Finland

Medical doctor

2.2

30.5

417

2338

JLC30

NOMESCO Finland

Pancreatoduodenectomy

19.8

29.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

29.2

269

1241

2115X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Liver and biliary passages[NEOPLASMA BENIGNUM ALIUD HEPATIS, VESIC FELLEAE ET]

+∞

28.2

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

4.8

27.9

212

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

11.2

27.5

WX002

NOMESCO Finland

Sedation and analgesia

2.2

27.4

334

1761

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.0

26.7

170

628

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.2

26.4

105

268

Z01.7

ICD-10 Finland

Laboratory examination

2.7

26.2

198

812

Z50.1

ICD-10 Finland

Other physical therapy

3.5

25.3

127

395

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

23.1

25.3

A09AA02

ATC

multienzymes (lipase, protease etc.)

6.6

25.2

105

JFA05

NOMESCO Finland

Endoscopic polypectomy in small intestine

59.3

25.1

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

24.3

321

1740

WZC30

SPAT

6.2

23.8

109

R4110

NOMESCO Finland

Physiotherapy

2.0

23.7

392

2329

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.6

23.5

113

339

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

23.5

395

2360

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

5.4

23.3

137

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.3

23.0

216

Z12.3

ICD-10 Finland

Special screening examination for neoplasm of breast

13.4

22.5

Z3226

NOMESCO Finland

Physiotherapist

2.1

22.4

288

1536

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

12.5

22.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

22.2

214

997

ZX120

NOMESCO Finland

Intravenous

2.6

22.2

172

713

UJD02

NOMESCO Finland

Gastroscopy

3.5

21.8

107

327

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

21.8

305

1685

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.5

21.4

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

8.0

21.2

K22.1

ICD-10 Finland

Ulcer of oesophagus

6.2

21.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

21.0

396

2448

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

21.9

20.9

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.8

20.9

140

530

UJK02

NOMESCO Finland

ERCP

5.2

20.7

130

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

20.5

616

4437

A02BC03

ATC

lansoprazole; oral

1.8

20.3

435

2804

N02AX02

ATC

tramadol; systemic, rectal

1.8

20.1

571

4028

JDH52

NOMESCO Finland

Endoscopic mucosal or submucosal resection in duodenum

+∞

19.8

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.2

19.8

193

JN4BD

NOMESCO Finland

Extensive body CT

2.3

19.7

196

923

JAH00

NOMESCO Finland

Laparotomy

5.0

19.6

134

N02BE01

ATC

paracetamol; systemic, rectal

2.1

19.6

1103

9679

K29.4

ICD-10 Finland

Chronic atrophic gastritis

4.9

19.5

139

J01DB01

ATC

cefalexin; oral

1.9

19.4

1014

8620

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

19.3

150

622

Z01.3

ICD-10 Finland

Examination of blood pressure

7.6

19.3

Z3231

NOMESCO Finland

Registered nurse

1.8

19.3

391

2466

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.9

18.9

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.6

18.9

258

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

18.8

139

557

JDH50

NOMESCO Finland

Local excision of lesion of duodenal bulb

+∞

18.8

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

101.5

18.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

18.5

517

3600

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

18.4

362

2249

K92.1

ICD-10 Finland

Melaena

3.1

18.3

104

354

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.7

18.3

140

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

18.0

174

808

SPAT1285

SPAT

Provision of consultation response

3.1

18.0

103

352

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

18.0

219

1130

B03BA03

ATC

hydroxocobalamin; parenteral

2.9

17.7

111

403

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

17.7

112

410

K30

ICD-10 Finland

Functional dyspepsia

2.3

17.7

169

780

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

17.4

157

703

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

12.2

17.4

A02BA02

ATC

ranitidine; systemic

1.9

17.3

302

1795

R03AC02

ATC

salbutamol; inhalant

1.7

17.1

640

4818

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

17.0

260

1468

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.3

16.8

153

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

6.0

16.7

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

16.7

286

1687

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.5

16.6

231

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.6

16.5

216

K63.8

ICD-10 Finland

Other specified diseases of intestine

40.6

16.4

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

2.3

16.3

160

746

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.9

16.3

100

359

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

10.6

16.2

B80

ICPC

Iron deficiency anaemia

5.7

16.1

OAB50

SPAT

6.2

15.7

D50.8

ICD-10 Finland

Other iron deficiency anaemias

6.7

15.5

P01AB01

ATC

metronidazole; oral, rectal

1.7

15.5

503

3608

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

15.1

470

3321

H02AB06

ATC

prednisolone; systemic

1.6

15.1

601

4538

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

14.9

803

6550

WX402

NOMESCO Finland

General anaesthesia

2.0

14.9

218

1209

ZXE00

NOMESCO Finland

One hour or less

1.6

14.8

494

3557

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.6

14.8

112

456

B01AB05

ATC

enoxaparin; parenteral

1.7

14.7

423

2921

R52.9

ICD-10 Finland

Pain, unspecified

2.4

14.6

127

559

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

14.6

241

1395

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

15.6

14.4

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

17.2

14.3

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

43.0

14.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

13.9

229

1320

XF404

NOMESCO Finland

Ambulatory ECG

2.2

13.9

148

716

C03CA01

ATC

furosemide; systemic

1.6

13.7

419

2929

N03AX16

ATC

pregabalin; oral

1.7

13.7

319

2061

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

13.6

197

1082

N06AB04

ATC

citalopram; systemic

1.8

13.6

281

1750

J01MA12

ATC

levofloxacin; systemic

1.8

13.6

261

1589

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

13.5

245

1462

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

9.5

13.5

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

16.4

13.5

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

3.0

13.4

277

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

13.4

263

1612

N05CF01

ATC

zopiclone; oral

1.6

13.4

432

3061

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

6.0

13.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

13.3

223

1296

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

13.2

338

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

13.1

309

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.2

12.9

221

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.3

12.9

199

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

12.8

137

664

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

6.4

12.8

ZXA00

NOMESCO Finland

Right side

1.6

12.7

375

2584

R4190

NOMESCO Finland

Nutritional therapy

3.6

12.7

159

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

15.6

12.6

K29.7

ICD-10 Finland

Gastritis, unspecified

3.1

12.6

225

R12

ICD-10 Finland

Heartburn

2.5

12.6

103

440

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

12.5

192

1080

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

12.4

558

4269

A02BC04

ATC

rabeprazole; oral

2.3

12.3

121

563

R06.0

ICD-10 Finland

Dyspnoea

1.7

12.2

335

2260

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

12.2

118

545

C07AB07

ATC

bisoprolol; oral

1.5

12.1

629

4968

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.3

12.0

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

4.8

12.0

N02AA05

ATC

oxycodone; systemic

1.8

12.0

212

1252

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.4

11.9

178

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

11.9

126

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

47.1

11.9

WX892

NOMESCO Finland

Monitored bed care

2.3

11.9

117

548

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

14.8

11.8

J01MA02

ATC

ciprofloxacin; systemic

1.5

11.7

498

3741

H02AB07

ATC

prednisone; oral

1.8

11.6

202

1187

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

11.2

11.6

ZXD05

NOMESCO Finland

Urgent procedure

1.6

11.5

370

2595

107

Kela drug reimbursment

Pernicious anaemia

3.9

11.5

120

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.8

11.4

283

K83.0

ICD-10 Finland

Cholangitis

5.6

11.4

3AC01

NOMESCO Finland

5.6

11.4

A07AA02

ATC

nystatin; oral

2.3

11.3

103

463

WZC00

SPAT

3.2

11.3

191

JFA73

NOMESCO Finland

Excision of lesion of small intestine

35.3

11.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

11.1

136

700

A03FA02

ATC

cisapride; oral, rectal

2.1

11.0

124

613

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.6

11.0

141

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

14.0

11.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

10.8

234

1466

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

10.8

159

878

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

10.7

327

2261

A06AD11

ATC

lactulose; oral

1.8

10.5

201

1214

K56.7

ICD-10 Finland

Ileus, unspecified

4.1

10.5

101

21121

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Duodeni

+∞

10.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

10.4

215

1330

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.7

10.3

C08CA01

ATC

amlodipine; oral

1.5

10.3

474

3600

WW500

NOMESCO Finland

Blood transfusion

2.7

10.2

266

K29.8

ICD-10 Finland

Duodenitis

6.3

10.2

XF402

NOMESCO Finland

ECG with work load test

1.9

10.1

162

920

J01FA06

ATC

roxithromycin; oral

1.5

10.1

482

3686

J01AA02

ATC

doxycycline; systemic

1.5

10.0

942

8303

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.4

10.0

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

40.4

10.0

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

6.8

9.9

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

7.7

9.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

9.9

441

3316

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

9.9

251

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

16.8

9.9

R51.80

ICD-10 Finland

Headache

1.9

9.9

162

929

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.7

9.9

JAH01

NOMESCO Finland

Laparoscopy

2.7

9.8

245

D13.0

ICD-10 Finland

Benign neoplasm: Oesophagus

10.7

9.8

Z71.8

ICD-10 Finland

Other specified counselling

1.6

9.7

263

1753

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

55.4

9.7

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.3

9.6

RD210

NOMESCO Finland

4.6

9.6

K59.0

ICD-10 Finland

Constipation

2.3

9.6

385

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

9.6

106

524

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

9.6

128

680

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

9.6

419

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

5.3

9.6

R03DC03

ATC

montelukast; oral

1.8

9.4

187

1140

TJX22

NOMESCO Finland

Excision of local lesion in gastrointestinal endoscopy

100.7

9.4

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.6

9.4

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

30.2

9.4

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

9.4

311

2182

2112X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Duodenum, jejunum and ileum[NEOPLASMA BENIGNUM ALIUD INTESTINI TENUIS, DUOD INC]

+∞

9.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

9.4

183

1110

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.8

9.4

102

N06AX21

ATC

duloxetine; oral

2.0

9.3

130

701

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

9.3

150

854

M79.6

ICD-10 Finland

Pain in limb

1.5

9.2

431

3261

A11CC03

ATC

alfacalcidol; systemic

3.5

9.2

119

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

9.2

142

798

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

9.2

103

513

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

9.1

134

738

JDA45

NOMESCO Finland

Endoscopic mucosal or submucosal resection in stomach or pylorus

37.0

9.0

R13

ICD-10 Finland

Dysphagia

2.2

9.0

451

UJH02

NOMESCO Finland

Anoscopy

2.6

8.9

262

AA1AD

NOMESCO Finland

CT of head and brain

1.5

8.9

311

2205

J45.8

ICD-10 Finland

Mixed asthma

3.1

8.9

161

A03DA02

ATC

pitofenone and analgesics; systemic

3.8

8.9

K29.1

ICD-10 Finland

Other acute gastritis

4.3

8.8

G44.2

ICD-10 Finland

Tension-type headache

1.8

8.8

157

926

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

9.6

8.8

M04AA01

ATC

allopurinol; systemic

1.7

8.8

181

1115

R03BA05

ATC

fluticasone; inhalant

1.7

8.7

213

1376

K92.0

ICD-10 Finland

Haematemesis

3.4

8.7

125

JDH28

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in duodenum

50.3

8.7

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.2

8.7

136

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

8.6

413

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

8.6

401

ZXA05

NOMESCO Finland

Left side

1.5

8.6

328

2374

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

8.6

213

1387

130

Kela drug reimbursment

Malignant tumour

2.0

8.5

112

592

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

8.5

110

580

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.5

8.4

112

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

8.4

500

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

8.4

129

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

8.3

212

1385

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

8.6

8.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

8.3

122

673

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

8.3

178

1110

C03DA01

ATC

spironolactone; oral

1.8

8.3

152

904

K83.1

ICD-10 Finland

Obstruction of bile duct

4.8

8.3

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.8

8.2

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.6

8.1

226

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

8.1

364

2720

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

33.6

8.1

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

17.3

8.1

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.4

8.1

276

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

8.1

278

1961

R03AC03

ATC

terbutaline; inhalant

1.7

8.0

165

1016

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

8.0

101

527

L01XE01

ATC

[U] imatinib; oral

22.2

8.0

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

22.2

8.0

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

8.0

309

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.3

8.0

309

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

8.0

270

K29.6

ICD-10 Finland

Other gastritis

4.4

8.0

WX110

NOMESCO Finland

Local anesthesy

1.4

7.9

761

6553

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.0

7.9

155

H01CB02

ATC

octreotide; parenteral

13.1

7.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

7.8

164

1015

Z2446

NOMESCO Finland

Social worker

2.2

7.8

388

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

7.7

239

189

Kela drug reimbursment

Imatinib

15.1

7.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

7.7

379

SPAT1324

SPAT

Screening procedure

1.7

7.7

157

966

R60.0

ICD-10 Finland

Localized oedema

1.7

7.7

147

887

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.4

7.7

R10.0

ICD-10 Finland

Acute abdomen

2.8

7.6

167

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

7.6

100

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.0

7.6

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.0

7.6

205

Kela drug reimbursment

Chronic hypertension

1.4

7.6

377

2872

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

7.5

193

C07AB02

ATC

metoprolol; systemic

1.5

7.5

273

1942

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

7.5

129

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

571

1730

4.92

177.22

2.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

361

1420

3.09

67.24

3.6

4.2

ug/l

7.9

21.6

1.25

297

1176

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

979

6417

2.80

66.18

9.2

6.3

umol/l

12.9

11.6

0.80

954

6085

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

187

500

4.17

62.96

3.6

3.4

u/ml

43.7

2911.0

0.83

152

435

(3024561) Albumin [Mass/volume] in Serum or Plasma

867

5483

2.56

60.76

7.9

4.8

g/l

34.5

35.0

1.63

827

5081

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

332

1333

2.96

58.82

4.1

2.7

umol/l

10.1

8.3

0.43

300

1174

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

593

3185

2.51

58.71

3.3

2.2

mg/l

3.6

3.1

3.47

531

2681

(3022948) Iron [Moles/volume] in Serum or Plasma

428

1989

2.67

57.11

3.8

2.5

umol/l

11.1

12.7

5.19

404

1843

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

666

3813

2.44

56.80

4.3

2.5

u/l

57.4

57.8

0.10

638

3500

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

388

1725

2.74

56.45

3.9

2.5

19.3

22.6

4.55

336

1478

(3032080) INR in Blood by Coagulation assay

829

5268

2.43

55.41

12.1

10.1

inr

1.3

0.16

162

1469

(3004789) Transferrin [Mass/volume] in Serum or Plasma

401

1830

2.68

55.24

3.8

2.5

g/l

2.4

2.3

1.08

378

1703

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

304

1216

2.92

53.78

2.9

2.1

g/l

0.2

1.54

282

1129

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

287

1127

2.95

52.40

3.7

2.3

u/l

52.7

40.5

0.48

262

952

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

628

3632

2.34

50.73

4.7

3.2

u/l

32.8

33.4

0.16

600

3449

(3013826) Glucose [Moles/volume] in Serum or Plasma

993

7138

2.39

45.84

6.9

4.9

mmol/l

6.8

0.40

948

6736

(3014576) Chloride [Moles/volume] in Serum or Plasma

353

1640

2.55

45.79

8.4

6.9

mmol/l

104.3

104.2

0.15

348

1598

(3044640) Blood type and Crossmatch panel - Blood

633

3858

2.18

42.99

3.9

2.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

897

6268

2.23

42.92

9.3

6.9

mmol/l

1.2

1.38

812

5272

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1174

9258

2.78

41.92

12.1

7.8

u/l

88.1

79.1

3.31

1139

8658

(3001604) Monocytes [#/volume] in Blood

841

5774

2.17

41.45

7.3

5.7

e9/l

0.6

0.10

736

4951

(3006315) Basophils [#/volume] in Blood

842

5794

2.16

41.11

7.3

5.7

e9/l

0.0

0.26

737

4983

(3001122) Ferritin [Mass/volume] in Serum or Plasma

731

4771

2.13

40.93

4.8

2.8

ug/l

105.6

143.3

5.84

681

4332

(3019198) Lymphocytes [#/volume] in Blood

852

5898

2.16

40.84

7.4

5.8

e9/l

1.8

1.9

0.82

760

5154

(3013115) Eosinophils [#/volume] in Blood

859

5992

2.15

40.01

7.7

5.9

e9/l

0.2

0.43

766

5227

(3019069) Monocytes/100 leukocytes in Blood

800

5451

2.11

39.39

7.8

6.2

8.6

8.8

0.96

758

5086

(3002032) Base excess in Venous blood by calculation

273

1203

2.58

38.94

5.1

3.6

mmol/l

1.8

2.0

0.37

233

957

(3018010) Neutrophils/100 leukocytes in Blood

799

5464

2.10

38.68

7.4

5.8

58.5

57.9

0.83

751

5096

(3006504) Eosinophils/100 leukocytes in Blood

795

5427

2.09

38.66

7.4

5.9

2.9

2.8

0.48

751

5040

(3002030) Lymphocytes/100 leukocytes in Blood

806

5550

2.09

38.04

7.6

6.1

26.2

26.9

1.02

761

5145

(3013650) Neutrophils [#/volume] in Blood by Automated count

932

6793

2.14

37.55

11.0

9.1

e9/l

4.4

4.2

1.52

833

5941

(3000570) Elastase.pancreatic [Mass/mass] in Stool

126

365

3.70

37.37

1.5

ug/g

225.8

274.5

2.04

223

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

773

5293

2.04

36.42

2.5

2.1

pmol/l

90.1

94.4

1.76

442

2686

(36304419) Bacteria [Presence] in Urine

554

3363

2.08

36.42

4.2

3.2

—

(3030467) Casts [#/volume] in Urine by Automated count

569

3499

2.06

36.01

4.3

3.2

e6/l

0.7

0.5

0.45

461

2697

(3033658) Prothrombin time (PT) actual/Normal

518

3084

2.09

35.73

6.7

3.9

86.4

88.4

0.88

507

3010

(3022096) Basophils/100 leukocytes in Blood

768

5278

2.02

35.45

7.4

5.9

0.7

0.31

726

4913

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

797

5583

2.01

34.46

6.4

4.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

311

1541

2.31

33.83

2.8

2.6

1.9

1.8

0.47

284

1367

(3024354) Oxygen [Partial pressure] in Venous blood

231

1004

2.56

33.55

4.3

2.9

kpa

4.5

0.02

226

968

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

425

2409

2.10

32.91

4.9

4.0

ng/l

102.7

325.8

4.28

351

1998

(3002582) Erythrocytes [#/volume] in Urine

591

3775

1.99

32.82

4.4

3.4

e6/l

28.5

81.0

2.20

491

2952

(3022145) Colonoscopy Study observation

281

1351

2.36

32.67

1.4

1.3

—

(3018095) Leukocytes [#/volume] in Urine

655

4353

1.96

32.23

5.0

3.8

e6/l

93.3

114.8

0.20

509

3173

(3023368) Bacteria identified in Blood by Culture

560

3556

1.97

31.23

5.8

4.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

327

1711

2.19

30.86

7.3

5.5

mmol/l

1.0

0.46

301

1566

(3026782) Osmolality of Urine

433

2523

2.04

30.76

3.2

2.8

mosm/kgh2o

519.9

548.0

1.79

370

2157

(3012095) Magnesium [Moles/volume] in Serum or Plasma

373

2072

2.10

30.06

3.9

3.2

mmol/l

0.8

0.70

346

1931

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

384

2157

2.08

30.04

3.3

2.8

e6/l

2.7

1.2

0.93

237

1278

(3048689) Calprotectin [Mass/mass] in Stool

256

1224

2.34

29.94

2.3

2.2

ug/g

155.0

149.4

0.10

216

958

(3000991) Gas panel - Venous blood

234

1076

2.41

29.89

8.0

8.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

163

632

2.79

29.55

1.7

1.9

g/l

1.6

0.21

138

551

(3021589) Normoblasts [#/volume] in Blood

727

5125

1.88

28.77

12.7

10.0

e9/l

0.0

0.39

607

4192

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

478

2962

1.94

27.95

3.7

2.4

—

(42870588) Differential panel, method unspecified - Blood

604

4043

1.88

27.84

6.7

5.8

—

(3000850) Epithelial cells [#/volume] in Urine

444

2695

1.95

27.52

3.2

2.6

e6/l

4.7

5.7

1.02

394

2376

(40758558) Short blood count panel - Blood

479

2996

1.92

27.05

8.3

6.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

349

1964

2.04

26.74

2.6

2.0

30.7

29.7

1.38

342

1905

(3020779) Urea [Moles/volume] in Serum or Plasma

235

1137

2.29

26.50

9.3

7.1

mmol/l

10.7

10.4

0.30

225

1085

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

287

1508

2.14

26.37

7.4

7.5

kpa

5.1

0.10

270

1443

(3027801) Oxygen [Partial pressure] in Arterial blood

287

1509

2.14

26.33

7.4

7.5

kpa

11.8

12.0

0.24

271

1446

(3003396) Base excess in Arterial blood by calculation

285

1500

2.13

26.05

7.4

7.5

mmol/l

1.0

1.2

0.28

232

1164

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

351

2000

2.01

25.86

3.6

3.0

e6/l

2.8

2.4

0.27

208

1128

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

232

1135

2.25

25.41

3.5

2.9

ng/l

218.4

217.4

0.01

211

1047

(3031040) Bacteria [#/volume] in Urine by Automated count

994

7909

1.91

25.27

6.3

4.9

e6/l

97.3

2211.4

—

125

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

204

950

2.35

25.07

2.2

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

415

2533

1.91

24.85

1.7

1.8

nmol/l

1138.8

1197.3

0.63

335

1868

(3013707) Erythrocyte sedimentation rate by Westergren method

1067

8746

1.97

24.09

5.4

4.3

mm/h

15.2

13.7

2.04

1002

8028

(3018418) pH of Serum or Plasma

555

3748

1.80

23.83

5.8

4.1

7.4

0.93

729

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

772

5753

1.77

23.54

8.6

6.1

mmol/l

1.2

3.47

721

5182

(3016502) Oxygen saturation in Arterial blood

255

1351

2.09

22.64

7.7

7.8

95.4

95.5

0.11

245

1303

(3023520) Reticulocytes [#/volume] in Blood

228

1172

2.13

21.86

2.4

2.7

e9/l

72.7

69.7

0.43

170

910

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

901

7113

1.77

21.59

4.5

3.2

u/l

65.7

52.4

2.35

845

6527

(3002173) Hemoglobin [Mass/volume] in Arterial blood

236

1242

2.09

21.23

8.0

8.3

g/l

116.6

119.9

1.72

226

1197

(3014111) Lactate [Moles/volume] in Serum or Plasma

221

1141

2.12

20.89

6.7

6.9

mmol/l

1.3

1.4

0.21

214

1100

(3021960) Folate [Moles/volume] in Serum or Plasma

472

3137

1.77

20.71

1.8

1.6

nmol/l

21.4

20.8

0.23

424

2617

(3042936) Bacteria identified in Isolate by Culture

310

1828

1.90

20.03

2.4

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

993

8155

1.77

19.73

5.6

4.7

—

(3037522) Nuclear Ab [Titer] in Serum

264

1492

1.95

19.31

1.4

1.3

titre

392.4

497.6

0.70

331

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

286

3.06

19.16

3.1

3.2

u/ml

550.0

1357.4

0.40

265

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1269

11352

2.44

19.06

29.2

16.0

mg/l

25.6

25.5

0.03

1122

9132

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

664

4924

1.67

19.04

2.8

2.3

nmol/l

77.5

79.0

0.65

606

4313

(3009261) Glucose [Presence] in Urine by Test strip

759

5836

1.67

18.84

4.7

4.0

estimate

0.0

0.50

1065

(3035350) Ketones [Presence] in Urine by Test strip

750

5761

1.66

18.59

4.6

4.0

estimate

0.0

0.00

1085

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

261

1493

1.92

18.34

4.3

4.0

u/l

231.4

250.8

1.72

245

1415

(3021601) Nitrite [Presence] in Urine by Test strip

750

5779

1.65

18.21

7.0

5.4

estimate

0.0

0.50

1093

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

389

2530

1.75

17.94

2.2

1.6

mg/l

1.2

1.3

0.64

312

1965

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

133

593

2.38

17.86

4.9

3.8

mmol/l

23.9

24.1

0.37

122

530

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

558

4006

1.66

17.77

3.5

3.1

ng/l

2014.2

1425.8

1.16

491

3446

(3014007) Fractional oxyhemoglobin in Arterial blood

168

828

2.17

17.76

8.3

9.2

93.8

93.7

0.09

168

820

(3015377) Calcium [Moles/volume] in Serum or Plasma

597

4367

1.65

17.62

3.5

3.4

mmol/l

2.3

2.4

1.74

531

3765

(3005719) IgG [Mass/volume] in Serum or Plasma

180

917

2.11

17.47

2.1

3.0

g/l

10.1

10.8

0.97

166

837

(3026008) Bacteria identified in Urine by Culture

547

3949

1.64

16.79

3.6

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

328

2075

1.76

16.47

1.5

g/l

2.7

2.5

0.51

198

1228

(3003338) MCHC [Mass/volume]

1068

9140

1.74

16.27

39.9

21.1

g/l

330.3

331.6

4.87

1061

9075

(3024980) IgG subclass 4 [Mass/volume] in Serum

174

3.44

16.27

1.5

1.8

g/l

0.8

0.9

0.09

134

(40768804) Tissue Pathology biopsy report

628

4717

1.61

16.23

2.5

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

192

1030

2.00

16.14

5.1

3.8

ng/l

119.7

89.1

3.04

162

885

(3007853) Bacteria identified in Skin by Aerobe culture

242

1406

1.87

16.06

2.2

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

144

695

2.20

16.00

8.5

10.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1030

8752

1.69

15.84

4.8

4.0

pmol/l

14.9

15.0

0.69

953

7859

(3028026) IgM [Mass/volume] in Serum or Plasma

149

734

2.15

15.73

1.7

1.9

g/l

1.2

1.6

1.51

138

671

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

252

1499

1.83

15.47

2.3

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

343

2.64

15.14

1.3

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1068

9212

1.70

14.96

35.7

19.5

14.3

13.8

11.05

1052

8994

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

250

1498

1.82

14.95

2.3

1.8

—

(4094501)

316

2.70

14.93

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

346

2.62

14.88

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

311

2.70

14.85

1.3

1.2

titre

88.0

83.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

177

3.26

14.49

2.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

120

562

2.24

14.33

2.5

1.9

ug/l

3.9

2.0

0.71

101

498

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

139

691

2.12

14.31

2.9

2.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

341

2.59

14.29

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

330

2.61

14.21

3.2

2.0

92.7

89.9

0.42

311

(3020630) Protein [Mass/volume] in Serum or Plasma

201

1143

1.89

14.15

2.7

2.9

g/l

65.3

66.4

1.34

187

1036

(3019150) Specific gravity of Urine by Refractometry

376

2575

1.63

13.69

5.0

4.5

kg/l

1.0

2.94

117

383

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

147

761

2.04

13.57

1.9

1.5

—

(3025941) Bacteria identified in Stool by Culture

125

609

2.16

13.54

1.5

1.3

—

(3000330) Specific gravity of Urine by Test strip

134

678

2.08

13.16

4.7

3.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

135

689

2.06

12.95

7.5

9.6

mmol/l

24.4

0.01

125

642

(3019060) Gas panel - Arterial blood

162

883

1.95

12.92

6.5

5.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

518

3870

1.54

12.81

2.1

2.2

u/l

219.5

223.1

0.02

496

3644

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

386

2.40

12.70

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

439

3167

1.57

12.67

3.5

2.8

umol/l

3164.6

6550.2

1.14

388

2700

(3008152) Bicarbonate [Moles/volume] in Arterial blood

153

826

1.96

12.54

9.5

7.2

mmol/l

24.1

24.5

0.48

144

769

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

317

2127

1.64

12.36

2.3

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

355

2.42

12.22

4.4

5.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

164

3.13

12.21

7.4

5.9

mg/l

11.0

12.1

0.77

154

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

337

2309

1.61

12.03

1.3

1.2

u/ml

2.0

1.5

0.14

608

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

618

4841

1.50

12.00

4.9

4.0

ng/l

40.8

49.0

0.25

465

3620

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

357

2483

1.59

11.96

3.4

3.0

mmol/l

2.5

0.31

316

2195

(40760892) CBC W Ordered Manual Differential panel - Blood

348

2411

1.59

11.83

5.3

4.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

264

2.62

11.71

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

264

2.62

11.71

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

388

2769

1.56

11.56

4.3

4.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

223

1388

1.72

11.50

1.5

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

183

1083

1.80

11.23

1.7

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

263

1728

1.64

11.03

33.7

27.7

inr

1.2

1.4

0.70

219

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

169

2.97

11.00

1.2

1.1

—

(3036489) Thrombin time

419

2.23

10.92

3.2

1.9

22.0

21.8

0.13

374

(3017143) Hepatitis C virus Ab [Presence] in Serum

173

1017

1.80

10.85

1.8

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

137

748

1.92

10.84

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

101

494

2.13

10.84

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1116

10005

1.60

10.54

33.1

17.3

37.6

39.0

4.08

708

6534

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

303

2.42

10.53

6.5

2.2

224.6

196.4

1.35

289

(3052851) Hemolysis interference index of Serum or Plasma

367

2.28

10.49

3.6

3.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1282

11987

1.96

9.73

33.7

18.8

mmol/l

139.4

139.6

2.89

1264

11680

(3007930) Methemoglobin/Hemoglobin.total in Blood

104

537

2.01

9.66

6.4

5.4

0.9

0.08

508

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.97

9.61

1.7

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

329

2.29

9.59

2.8

2.5

ug/min

139.3

86.0

0.32

196

(3023103) Potassium [Moles/volume] in Serum or Plasma

1283

12012

1.95

9.50

33.9

18.9

mmol/l

4.0

2.49

1262

11687

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

459

2.08

9.39

3.1

2.5

u/ml

0.3

0.4

0.65

266

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

104

544

1.99

9.32

6.3

5.4

1.6

0.28

514

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

276

1907

1.56

9.24

1.3

iu/ml

37.0

39.6

0.11

620

(3023183) Ammonium ion [Moles/volume] in Plasma

278

2.37

9.15

4.5

2.7

umol/l

36.5

33.5

0.34

233

(3024139) IgG subclass 3 [Mass/volume] in Serum

106

3.26

9.07

1.2

1.5

g/l

0.5

0.4

0.21

(3027135) IgG subclass 1 [Mass/volume] in Serum

106

3.26

9.07

1.2

1.5

g/l

6.7

7.3

0.41

(3028192) IgG subclass 2 [Mass/volume] in Serum

106

3.26

9.07

1.2

1.5

g/l

3.0

2.7

0.35

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

160

2.81

9.03

1.1

g/l

1.5

1.6

0.87

143

(3036603) Volume of Urine

3.64

8.86

1.5

1.6

1794.2

1894.8

0.24

(4062490)

109

3.17

8.68

1.2

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

194

1250

1.64

8.67

1.9

1.6

—

(3044889) 12 lead EKG panel

957

8431

1.44

8.66

5.0

4.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

131

2.95

8.59

1.1

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1149

10508

1.55

8.50

6.0

4.9

mu/l

1.9

2.1

0.89

1081

9470

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

143

2.85

8.48

5.2

3.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

125

718

1.81

8.44

6.3

7.9

mmol/l

25.4

24.9

0.89

125

712

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

263

1832

1.54

8.43

1.3

1.2

u/ml

27.8

12.2

0.46

102

681

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

338

2.16

8.20

1.4

1.5

g/l

0.2

0.10

321

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

184

1186

1.64

8.20

2.7

2.5

ug/l

5.3

7.1

1.47

164

1039

(3021879) Hepatitis B virus core Ab [Presence] in Serum

113

640

1.83

7.99

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.56

7.99

1.8

1.7

15.1

14.2

0.11

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

3.24

7.97

1.2

1.1

titre

350.0

160.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

266

2.27

7.79

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

482

3824

1.40

7.76

3.3

mg/l

1144.2

311.8

1.58

322

2413

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

354

2.09

7.67

1.4

1.5

g/l

1.2

0.08

337

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

546

1.88

7.62

2.3

2.7

g/l

3.8

0.12

391

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.87

7.58

2.3

2.7

g/l

7.3

7.5

0.61

407

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

231

2.35

7.57

5.2

5.4

iu/ml

115.3

922.0

—

(4035726)

172

1112

1.62

7.56

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

512

1.90

7.52

2.3

2.7

g/l

9.6

10.5

0.96

432

(3036481) Cortisol [Moles/volume] in Serum or Plasma

168

1083

1.63

7.47

2.4

2.2

nmol/l

346.4

373.5

0.90

153

987

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.22

7.46

1.3

3.7

—

(4010399)

143

885

1.69

7.45

1.5

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.85

7.27

2.3

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

268

2.22

7.24

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

543

4433

1.37

7.22

5.4

4.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

153

974

1.64

7.15

2.0

2.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

428

1.95

7.10

1.3

1.2

u/ml

4.7

1.0

—

(3020891) Body temperature

534

1.84

6.90

8.1

4.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

148

2.61

6.90

1.2

u/ml

89.7

57.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

103

2.96

6.87

1.5

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

499

4045

1.37

6.85

3.9

4.0

mg/mmol

20.8

8.8

2.64

329

2532

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.13

6.82

3.4

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

204

2.35

6.80

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

472

1.88

6.74

2.6

3.8

mg/l

41.4

57.9

0.53

390

(3034860) Kappa light chains.free [Mass/volume] in Serum

472

1.88

6.74

2.6

3.8

mg/l

102.0

65.4

0.35

388

(40761511) CBC panel - Blood by Automated count

1244

11721

1.61

6.62

28.1

15.4

—

(3011412) CD3 cells [#/volume] in Blood

100

2.94

6.60

2.1

1.8

e9/l

1.1

1.0

0.21

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

172

2.43

6.41

1.3

1.4

u/ml

127.9

107.5

1.20

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

3.01

6.40

1.1

1.3

—

(3002256) Pathology report gross observation

215

1522

1.49

6.28

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

359

2796

1.38

6.21

1.8

1.7

pmol/l

31013124.8

20355200.2

0.13

316

2255

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1274

12103

1.67

6.20

17.1

11.2

u/l

26.3

25.2

1.32

1254

11635

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

692

5951

1.33

6.20

2.9

2.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

350

1.96

6.10

2.0

4.0

—

(3000494) Fungus identified in Specimen by Culture

202

1422

1.49

6.06

1.8

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

154

2.44

5.90

1.3

1.2

u/ml

2.1

2.4

0.17

(44790047)

142

2.50

5.89

1.7

1.5

—

(44806118)

142

2.50

5.89

1.7

1.5

—

(44790048)

142

2.50

5.89

1.7

1.5

—

(44790049)

142

2.50

5.89

1.7

1.5

—

(3013512) EKG study

465

3808

1.33

5.74

5.4

4.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

4.68

5.74

1.2

1.0

u/ml

0.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

351

1.92

5.73

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

323

1.96

5.71

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

325

1.95

5.61

1.5

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

152

2.41

5.58

1.5

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.84

5.54

1.7

1.2

g/l

9.0

15.5

2.62

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

4.52

5.51

1.2

g/l

0.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

245

2.08

5.46

1.4

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.37

5.45

2.1

2.8

u/ml

547.1

1129.5

1.66

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

146

989

1.53

5.25

2.7

2.9

ml/min/173m2

53.8

62.1

2.01

411

(3041096) Erythrocytes [Presence] in Urine by Automated

378

3039

1.34

5.21

4.7

3.6

—

(3000492) Spirometry study

146

992

1.53

5.18

1.6

1.5

—

(3024471) HLA-A [Type]

4.22

5.09

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

252

2.02

5.08

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

266

1.99

5.07

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.20

5.05

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

126

834

1.56

5.03

1.9

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

404

1.80

5.03

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

2.72

5.02

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

173

2.23

5.00

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

122

809

1.56

4.84

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

508

1.70

4.82

2.5

2.7

g/l

3.3

3.2

0.30

397

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

196

2.13

4.80

1.3

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

152

2.27

4.69

1.2

u/ml

10.3

4.9

0.28

(3042733) HLA Ab [Presence] in Serum

4.17

4.63

2.9

4.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

101

648

1.60

4.62

3.1

2.8

e6/l

0.2

0.3

0.63

101

632

(3017817) Protein [Mass] in Urine collected for unspecified duration

128

2.37

4.59

2.5

2.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

130

2.34

4.45

1.1

1.2

u/l

53.0

49.3

0.25

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1151

10852

1.36

4.39

8.1

6.3

mmol/mol

41.3

40.5

1.92

1085

9923

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

100

2.53

4.39

1.1

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

147

1038

1.47

4.35

4.6

4.1

1.1

0.9

0.14

314

(21494890) Protein electrophoresis panel - 24 hour Urine

151

2.21

4.33

2.1

2.2

—

(3009508) Creatinine [Moles/volume] in Urine

465

3926

1.28

4.32

3.2

mmol/l

7.1

7.2

0.28

389

3251

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

471

1.67

4.27

2.5

2.9

g/l

0.9

1.6

1.05

408

(3024932) HLA-DR beta [Type]

3.90

4.26

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.86

4.23

2.3

1.9

e9/l

0.2

0.21

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

381

1.74

4.21

2.6

2.7

g/l

0.0

0.00

355

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

351

1.77

4.21

1.4

1.6

iu/ml

0.1

0.29

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

404

1.72

4.20

2.5

2.7

g/l

0.0

0.86

374

(44813793)

2.82

4.13

1.2

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.82

4.13

2.3

1.9

e6/l

420.5

593.2

0.55

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

384

1.73

4.10

2.6

2.7

g/l

0.0

0.00

356

(3033799) Differential panel - Peritoneal fluid

3.36

4.05

2.9

2.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

169

2.10

4.04

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

654

1.55

4.03

2.9

3.1

pmol/l

4.2

4.4

2.26

566

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.62

3.98

1.5

1.6

u/l

3.4

7.7

0.79

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

254

1.88

3.97

1.5

1.6

nmol/l

0.8

0.9

0.32

210

(4211845)

3.04

3.97

4.4

3.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.79

3.86

2.6

2.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.03

3.82

1.9

1.5

—

(3024928) Oxygen saturation in Venous blood

280

1.82

3.80

2.7

2.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

363

1.71

3.77

1.9

1.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

223

1.91

3.76

3.3

2.1

65.6

60.8

0.62

223

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

433

1.65

3.75

2.5

g/l

36.8

37.2

0.23

371

(4306422)

141

2.15

3.72

1.2

—

(3025159) Blasts/100 leukocytes in Blood

129

918

1.45

3.69

4.1

4.3

0.0

0.4

0.57

241

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

100

676

1.52

3.69

1.2

1.4

—

52.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

136

978

1.43

3.68

4.7

4.2

0.2

0.1

0.21

283

(3003888) Timothy IgE Ab [Units/volume] in Serum

103

2.35

3.68

1.2

1.0

u/ml

1.0

3.6

1.50

(3007461) Platelets [#/volume] in Blood

1289

12461

1.51

3.66

43.5

23.6

e9/l

248.0

246.4

0.33

1264

12115

(3024731) MCV [Entitic volume]

1289

12463

1.51

3.63

43.3

23.5

91.1

91.5

2.24

1277

12254

(3035941) MCH [Entitic mass]

1289

12464

1.51

3.62

43.3

23.5

30.2

30.4

4.35

1277

12254

(3026361) Erythrocytes [#/volume] in Blood

1289

12465

1.51

3.61

43.5

23.6

e12/l

4.3

4.4

9.04

1257

12082

(3010813) Leukocytes [#/volume] in Blood

1289

12466

1.51

3.59

43.5

23.6

e9/l

7.0

6.7

2.98

1257

12081

(3000963) Hemoglobin [Mass/volume] in Blood

1289

12468

1.50

3.57

43.8

23.7

g/l

129.0

133.7

20.25

1277

12255

(40761535) Cells panel - Urine sediment

147

1079

1.41

3.55

4.6

3.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

131

2.16

3.53

1.2

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

6.18

3.50

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

489

1.59

3.50

1.0

—

(3039000) Anion gap in Blood

288

1.76

3.48

9.2

7.5

mmol/l

11.8

11.1

0.59

262

(3018572) Chloride [Moles/volume] in Blood

288

1.76

3.48

9.2

7.5

mmol/l

104.9

105.5

0.31

262

(3006462) Nitrate [Presence] in Urine

3.00

3.41

3.8

3.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

231

1.84

3.40

1.5

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1143

10863

1.30

3.39

24.4

14.9

ml/min/173m2

74.9

76.0

0.94

1013

9019

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

147

2.06

3.38

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

306

1.73

3.38

1.3

1.2

u/ml

1.8

2.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

247

1.81

3.35

1.3

1.2

u/ml

10.6

6.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

315

1.71

3.33

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

634

0.54

3.30

1.3

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

135

2.10

3.29

1.3

1.2

nmol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

301

1.72

3.28

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

249

1.79

3.27

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

310

1.70

3.24

1.3

1.2

u/ml

2.2

11.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.35

3.19

1.5

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

137

2.07

3.18

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.37

3.16

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

472

1.55

3.09

2.3

2.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.82

3.09

1.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.70

3.06

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

522

1.52

3.06

1.7

2.0

u/l

37.5

39.3

0.29

461

(3035637) Corticotropin [Mass/volume] in Plasma

133

2.05

3.02

1.8

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.31

2.99

1.1

1.2

—

(3051651) Icteric interference index of Serum or Plasma

2.36

2.99

3.9

3.0

—

(3047181) Lactate [Moles/volume] in Blood

389

1.59

2.95

8.5

6.8

mmol/l

1.6

1.3

1.00

343

(3027456) Digoxin [Moles/volume] in Serum or Plasma

320

1.65

2.91

3.3

3.2

nmol/l

0.8

0.28

252

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.41

2.87

1.9

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.94

2.86

1.7

1.6

—

(40768443) Skin Pathology biopsy report

524

1.50

2.81

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

117

2.07

2.78

1.3

1.1

u/ml

1.7

1.3

0.26

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.24

2.77

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

145

1.95

2.76

1.2

—

(3044941) Cell count panel - Synovial fluid

203

1.79

2.75

1.7

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

142

1084

1.35

2.73

2.1

1.8

1.7

1.5

1.11

118

910

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.02

2.73

1.4

1.1

113.9

96.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.02

2.73

1.6

umol/l

50.4

50.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.02

2.73

1.4

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

226

1.75

2.72

1.5

—

(40768441) Liver Pathology biopsy report

2.16

2.71

1.5

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

681

0.60

2.68

2.2

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1177

11305

1.28

2.68

5.6

5.0

mmol/l

6.2

6.0

5.05

1095

10128

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

140

1.95

2.66

2.3

2.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

100

2.12

2.59

1.2

1.1

u/ml

0.5

2.1

—

(3003181) Sodium [Moles/volume] in Urine

246

1.69

2.55

1.5

1.3

mmol/l

61.4

61.0

0.02

198

(3025130) Human papilloma virus identified in Specimen

2.24

2.54

1.5

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

172

1.82

2.51

1.9

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

318

1.59

2.49

2.1

1.7

e6/l

11336.5

15396.1

0.48

237

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.40

2.46

1.2

1.0

—

(3017732) Neutrophils [#/volume] in Blood

104

770

1.38

2.45

2.3

3.0

e9/l

4.2

4.1

0.08

570

(4268621)

103

2.05

2.42

2.0

2.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

266

1.64

2.40

1.8

1.4

—

(3021901) Oxygen saturation in Capillary blood

243

1.67

2.39

3.1

3.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.22

2.38

1.2

u/l

19.3

18.0

0.08

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

284

1.60

2.33

1.8

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

177

1.77

2.31

1.4

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.63

2.27

3.3

5.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

106

2.00

2.26

1.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

1014

0.70

2.25

4.2

4.0

—

(3025315) Body weight

5.57

2.21

4.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

180

1.74

2.20

1.1

1.2

u/ml

279.7

282.9

0.02

102

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

313

1.55

2.19

4.1

3.3

mg/l

1.7

0.14

283

(3017704) Immunofixation for Urine

2.08

2.17

2.1

1.7

—

(3035880) pH of Pleural fluid

2.08

2.17

1.1

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

420

1.47

2.16

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.31

2.15

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.31

2.15

1.1

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.11

2.13

1.2

u/l

74.5

80.2

0.24

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.22

2.11

2.3

2.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

190

1.70

2.11

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

357

1.50

2.10

1.6

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

661

1.37

2.09

1.2

iu/ml

118.4

144.5

0.31

244

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.27

2.08

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.99

2.06

5.8

4.5

u/ml

385.2

29.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

135

1072

1.29

2.01

4.0

3.8

mmol/l

1.2

0.43

126

934

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.23

2.01

1.1

u/l

83.2

82.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.23

2.01

1.1

u/l

24.0

22.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.36

1.95

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

226

1.61

1.95

1.5

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

2.97

1.93

5.8

3.7

ml/dl

13.8

15.1

—

(3037756) Immunofixation for Serum or Plasma

323

1.50

1.93

1.5

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

166

1.70

1.88

1.8

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

174

1.68

1.87

1.7

1.3

e6/l

1310.7

1699.7

0.48

128

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.04

1.85

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

122

1.82

1.84

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.18

1.82

1.4

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

4.18

1.82

1.0

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.07

1.81

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.07

1.81

3.5

4.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.07

1.81

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.99

1.75

2.3

2.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

100

780

1.30

1.73

3.9

mmol/l

1.8

2.0

0.13

594

(3028308) Erythrocytes [#/volume] in Pleural fluid

155

1.69

1.73

1.5

1.3

e6/l

125662.6

111102.3

0.06

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

194

1.61

1.72

1.2

1.3

miu/ml

101.9

223.7

—

(3052592) Norovirus Ag [Presence] in Stool

2.93

1.72

1.4

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

202

1.60

1.72

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

133

1.74

1.70

3.9

3.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2.07

1.70

1.8

nmol/l

18.7

17.9

0.09

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

105

828

1.29

1.68

3.9

kpa

5.1

5.2

0.23

774

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

140

1144

1.25

1.68

1.7

1.6

—

(3023419) Bacteria identified in Sputum by Culture

188

1.61

1.67

5.1

2.5

—

(3034426) Prothrombin time (PT)

2.59

1.66

1.1

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

131

1598

0.80

1.65

4.4

4.8

33.1

0.02

1035

(3002179) Metamyelocytes/100 leukocytes in Blood

117

939

1.27

1.64

4.2

3.9

0.5

0.27

224

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

181

1.62

1.64

1.5

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

135

1.72

1.63

1.5

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

114

1.77

1.57

2.0

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.04

1.54

7.5

6.2

—

(3003694) ABO and Rh group [Type] in Blood

326

2906

1.16

1.54

1.5

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.98

1.54

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.98

1.54

1.3

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.34

1.52

1.2

1.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

375

1.40

1.52

1.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

116

1.73

1.49

1.9

1.4

28.0

30.0

0.08

(40768800) Prostate Pathology biopsy report

268

0.55

1.48

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

155

1.62

1.47

1.5

—

(3009343) pH of Capillary blood

102

818

1.27

1.46

3.9

7.4

—

110

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.13

1.44

2.2

1.3

—

(3011648) Oxygen content in Venous blood

1.80

1.43

1.4

1.6

12.2

10.7

0.81

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

157

1.60

1.41

1.6

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

157

1.60

1.41

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

127

1.66

1.37

1.5

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.14

1.34

1.2

1.0

—

(4281824)

128

1.65

1.33

1.5

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.92

1.33

1.7

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.79

1.33

1.4

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.05

1.33

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.10

1.30

1.2

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.77

1.29

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1.73

1.27

1.7

u/l

1172.8

5052.2

—

(3044007) Cell count panel - Peritoneal fluid

2.05

1.27

3.3

2.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

219

1.47

1.26

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

398

0.67

1.25

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

123

1.64

1.24

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

123

1.64

1.24

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

123

1.64

1.24

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.23

1.24

1.0

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.01

1.23

1.4

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.97

1.22

1.2

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.05

1.22

1.2

1.8

mg/l

56.8

70.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

156

1338

1.19

1.21

4.3

3.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

156

1.55

1.20

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

156

1.55

1.20

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

157

1.54

1.17

1.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

207

1.46

1.15

2.2

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.51

1.15

1.0

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

429

3972

1.12

1.11

5.2

5.3

ug/l

2.3

3.0

1.18

378

3520

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.26

1.10

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

569

1.26

1.08

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1182

11568

1.15

1.07

5.9

5.3

mmol/l

2.5

2.7

6.38

1084

10471

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.76

1.07

1.2

1.5

promille

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

153

1.51

1.06

1.2

1.1

—

14.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.13

1.05

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

170

1.48

1.05

5.1

4.6

umol/l

356.6

359.6

0.03

149

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.28

1.03

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

215

0.60

1.03

2.5

1.9

mmol/l

2.0

1.6

0.42

209

(3022313) Gas panel - Capillary blood

600

1.25

1.03

3.7

4.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1113

10858

1.13

1.02

4.7

4.2

mmol/l

1.3

1.48

1016

9725

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1148

11227

1.13

0.99

5.1

4.7

mmol/l

1.4

1.5

6.70

1052

10141

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.84

0.98

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.81

0.98

1.3

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.18

0.98

1.8

1.1

—

(3020650) Glucose [Presence] in Urine

0.00

0.97

0.0

1.4

—

(40768446) Kidney Pathology biopsy report

1.95

0.97

1.7

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

207

1.41

0.97

4.7

3.8

0.8

1.4

0.89

168

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

100

1.61

0.97

1.0

—

(3012441) Differential panel - Pleural fluid

142

1.49

0.92

1.5

1.4

—

(1616796) Gas panel - Central venous blood

270

1.34

0.91

4.3

4.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

111

1.54

0.88

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.00

0.87

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.00

0.87

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.00

0.87

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.00

0.87

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

238

1.35

0.86

1.5

1.6

—

(3022621) pH of Urine by Test strip

829

1.18

0.84

3.5

3.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

180

1.40

0.82

1.3

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

233

1.34

0.79

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

139

1.45

0.79

1.5

1.7

—

(3045142) Bone marrow Pathology biopsy report

156

1.42

0.79

1.5

1.3

—

(21494434) Karyotype in Bone marrow

131

1.46

0.78

1.1

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

1.5

—

(3016038) Potassium [Moles/volume] in Urine

1.56

0.78

1.4

1.1

mmol/l

29.2

34.5

0.61

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.59

0.78

1.0

1.4

—

66.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

449

0.77

0.76

1.7

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

107

1.50

0.76

3.1

2.1

u/field

3.2

2.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.70

0.76

1.0

1.1

—

9.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.65

0.75

1.3

1.4

—

(3017569) Oxygen content in Arterial blood

1.61

0.75

2.2

2.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.09

0.74

2.6

1.7

mmol/l

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.67

0.74

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

142

1.41

0.72

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.67

0.72

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.67

0.72

1.5

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

117

1.46

0.72

1.5

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.62

0.71

2.5

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

179

1623

1.12

0.70

14.6

7.7

—

(3008295) Osmolality of Serum or Plasma

135

1.41

0.69

1.4

1.3

mosm/kgh2o

273.1

276.5

0.28

(3037121) Protein [Mass/volume] in Urine

456

1.21

0.68

3.2

3.1

g/l

0.4

0.3

0.66

177

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.67

0.68

1.0

1.1

miu/ml

2616.9

1685.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.49

0.67

1.4

1.2

u/ml

0.1

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

137

1.39

0.64

1.0

—

(40768806) Pleura Pathology biopsy report

146

1.38

0.64

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1150

11318

1.10

0.62

5.2

4.7

mmol/l

4.4

4.6

8.90

1061

10301

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

156

1.35

0.61

1.9

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.60

0.0

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.60

0.0

2.4

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.60

0.0

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

272

1.26

0.60

1.7

1.3

e6/l

1451.2

710.3

0.24

221

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

272

1.26

0.60

1.5

1.3

e6/l

18.7

45.9

0.55

212

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.57

0.58

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

282

1.25

0.58

2.9

2.3

g/l

122.7

128.3

0.85

212

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

273

1.25

0.58

1.9

1.7

iu/l

4.1

4.7

0.18

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

106

1.42

0.57

1.6

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.46

0.56

1.0

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.46

0.56

1.0

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

194

1.29

0.56

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

124

1.38

0.56

1.5

1.3

—

(3019225) pH of Specimen

119

1319

0.89

0.55

5.0

4.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

183

0.71

0.55

2.0

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.47

0.54

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.47

0.54

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.47

0.54

1.3

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.54

0.53

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.53

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.45

0.52

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.45

0.52

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.45

0.52

1.3

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.50

0.51

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.50

0.51

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.50

0.51

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.50

0.51

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.50

0.51

1.3

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.47

0.50

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.56

0.49

6.6

2.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.52

0.48

1.7

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

208

1.25

0.48

2.2

1.5

mu/l

358.7

288.3

0.53

191

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

252

0.79

0.43

1.4

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.62

0.43

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.43

0.42

1.0

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.56

0.42

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

158

1.27

0.42

1.7

1.6

46.9

63.7

0.77

104

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.38

0.41

1.5

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

5.4

—

(44806071)

0.00

0.41

0.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.47

0.40

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

560

0.87

0.40

2.0

1.9

—

(3051593) INR in Capillary blood by Coagulation assay

1.31

0.39

10.0

14.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.43

0.39

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

514

1.13

0.38

4.2

4.3

mmol/l

24.7

25.0

0.41

480

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.39

0.38

4.0

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.39

0.38

4.0

2.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.35

0.37

1.2

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

300

0.83

0.37

2.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.39

0.37

2.8

1.5

g/l

0.9

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

1.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

1.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

1.0

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

1.0

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.43

0.35

1.3

1.4

—

(3048879) Bone marrow aspiration report

1.43

0.35

1.3

1.7

—

(4024509)

126

0.71

0.35

1.8

1.6

—

(3042631) Mycobacterium sp identified in Specimen

200

0.80

0.34

1.9

2.7

—

(4034850)

379

1.14

0.32

12.3

11.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.35

0.32

1.6

1.5

—

69.2

—

(3024263) Appearance of Synovial fluid

1.35

0.32

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

154

0.78

0.32

5.0

4.3

—

(3005570) Glucose [Moles/volume] in Urine

142

0.77

0.30

1.6

2.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

184

1.20

0.30

1.5

1.3

u/l

15.4

11.1

0.41

142

(3023323) Follitropin [Units/volume] in Serum or Plasma

250

1.16

0.29

1.4

1.3

iu/l

25.6

34.4

0.78

212

(3017446) Testosterone [Moles/volume] in Serum or Plasma

737

1.09

0.29

2.5

2.2

nmol/l

14.3

12.9

0.23

636

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.23

0.29

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

162

0.80

0.28

1.1

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.29

0.28

1.1

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

226

0.84

0.27

2.4

3.2

e9/l

3.8

4.4

0.46

226

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

236

0.85

0.27

2.7

3.5

57.5

58.4

0.10

236

(1761868) Lipid panel - Serum or Plasma

350

3609

0.96

0.26

3.8

3.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

299

0.87

0.26

1.8

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

179

1.18

0.25

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.28

0.24

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.28

0.24

1.0

1.2

—

(4146454)

152

1.19

0.23

3.1

2.6

—

(3029075) Extractable nuclear Ab panel - Serum

1.32

0.23

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.32

0.23

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1.32

0.23

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.32

0.23

1.2

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.28

0.23

1.2

2.6

—

55726.6

—

(3008898) HLA-B27 [Presence]

304

1.12

0.22

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.25

0.22

1.0

1.1

iu/ml

116.5

254.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

5.9

—

0.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3010421) pH of Blood

344

1.11

0.21

5.4

4.5

7.4

0.68

275

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

865.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

330

3213

1.04

0.21

4.8

4.5

20.9

21.2

0.14

171

1620

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

11.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

518

1.08

0.21

1.9

2.0

—

(40765096) Chromosome analysis panel by Banding

1.23

0.20

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

165

1.15

0.19

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

128

1.17

0.18

1.1

—

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

325

3173

1.03

0.18

5.1

4.3

estimate

0.0

0.88

1049

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.17

0.17

6.3

5.2

—

49.3

—

(3028300) Cannabinoids [Presence] in Urine

163

0.86

0.17

1.1

1.4

—

(3027008) Opiates [Presence] in Urine

163

0.86

0.17

1.1

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.13

0.17

2.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

205

0.88

0.17

1.6

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.18

0.16

2.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.10

0.15

2.0

2.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.79

0.15

1.0

1.6

—

(3000012) Reticulocyte production index

0.78

0.15

1.0

1.7

—

(3027944) Amphetamines [Presence] in Urine

161

0.87

0.15

1.1

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

478

1.07

0.15

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.10

0.15

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.08

0.14

3.0

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.08

0.14

1.7

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

103

1.17

0.13

1.2

1.0

—

(3049717) Cytology report of Urine Cyto stain

539

1.06

0.13

3.1

2.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

324

3180

1.02

0.13

1.6

1.7

mmol/l

1.4

0.62

284

2632

(3016879) Cocaine [Presence] in Urine

148

0.88

0.12

1.1

1.4

—

(40768793) Breast Pathology biopsy report

293

0.92

0.12

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

116

0.86

0.12

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

172

1.11

0.11

2.8

2.4

mg/l

21.6

26.6

—

(1002224) Polysomnography panel

377

1.06

0.11

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

115

0.87

0.10

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

280

1.07

0.10

3.7

2.6

15.9

0.05

145

(3028433) Virus identified in Specimen by Culture

1.14

0.10

1.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.11

0.09

1.0

2.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

289

0.93

0.09

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

126

1.11

0.09

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.82

0.08

3.0

4.0

—

(3004451) EKG impression Narrative

0.84

0.07

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.86

0.07

1.5

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.83

0.07

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

276

0.94

0.07

4.0

3.7

mg/l

49.6

25.9

1.44

171

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

149

1463

1.02

0.07

1.5

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.03

0.07

1.3

1.5

—

(3011288) Drugs identified in Urine by Screen method

109

1.10

0.06

1.2

1.8

—

(3023410) Appearance of Cerebral spinal fluid

121

1.08

0.03

1.9

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

149

0.94

0.03

1.6

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

282

1.03

0.02

5.8

4.9

kpa

8.7

8.4

0.37

277

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

107

0.93

0.02

1.4

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

453

1.02

0.01

1.8

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

116

0.95

0.00

1.5

2.1

—

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

101

0.99

0.00

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

121

0.99

0.00

1.0

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

281

1.00

0.00

5.8

4.9

kpa

5.0

5.1

0.25

276

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

223

0.99

0.00

3.6

2.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

505

1.01

0.00

1.8

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

230

2305

1.00

0.00

2.9

3.2

ug/l

0.7

0.8

0.92

177

1574

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

33.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

7.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.5

—

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.00

0.00

2.3

2.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

0.98

0.00

2.2

2.1

ug/l

2.3

3.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.93

0.00

1.2

1.1

—

(3012501) Base excess in Blood by calculation

280

1.00

0.00

5.8

4.9

mmol/l

3.1

2.7

0.22

199

(3014271) Vancomycin [Susceptibility]

1.01

0.00

3.3

2.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3012565) Volume of 24 hour Urine

1.00

0.00

2.0

2.9

1521.7

1822.1

—

(3006653) Thiamine [Moles/volume] in Blood

0.87

0.00

1.8

1.3

nmol/l

146.2

148.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_SMALL_INTESTINE and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_SMALL_INTESTINE	1.491 [1.32, 1.68]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.56

During the follow-up period (1.1.1998 — 31.12.2019), 874 out of 3407 females with CD2_BENIGN_SMALL_INTESTINE died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_SMALL_INTESTINE	1.557 [1.36, 1.78]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 982 out of 2911 males with CD2_BENIGN_SMALL_INTESTINE died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_SMALL_INTESTINE.

N-year risk	Females	Males
1	0.111%	0.27%
5	0.822%	1.908%
10	2.147%	4.633%
15	4.295%	8.976%
20	7.835%	15.246%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_SMALL_INTESTINE – Benign neoplasm: Small intestine

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Small intestine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints